Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron C Shaver

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Blood Advances|April 27, 2021
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AMLEmily F Mason, Olga Pozdnyakova, Mikhail Roshal, et al.
Blood Advances|February 12, 2020
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignanciesMelissa A Fischer, Sharon Y Friedlander, Maria P Arrate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition TherapyDaniel N Cohen, Steven K Lawson, Aaron C Shaver, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
Cell Genomics|October 23, 2023
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome predictionGeorge J Xu, Matthew A Loberg, Jean-Nicolas Gallant, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Blood Advances|April 27, 2021
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AMLEmily F Mason, Olga Pozdnyakova, Mikhail Roshal, et al.
Blood Advances|February 12, 2020
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignanciesMelissa A Fischer, Sharon Y Friedlander, Maria P Arrate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition TherapyDaniel N Cohen, Steven K Lawson, Aaron C Shaver, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
Cell Genomics|October 23, 2023
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome predictionGeorge J Xu, Matthew A Loberg, Jean-Nicolas Gallant, et al.
Pageof 3